Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events
Ezetimibe is a relatively new drug that inhibits the absorption of dietary cholesterol in the small intestine. It is an LDL-cholesterol lowering medication that acts directly on the intestine by inhibiting Niemann-Pick C1 Like1 (NPC1L1). Recently, results of the ARBITER 6-HALTS trial (Arterial Biolo...
Main Authors: | Ahmed, M.H (Author), Byrne, Christopher D. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2010-11.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.
by: Kentaro Sakamoto, et al.
Published: (2015-01-01) -
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
by: Ryan C Neal, et al.
Published: (2006-03-01) -
The lipid-lowering effect of ezetimibe in pure vegetarians
by: Jacob J. Clarenbach, et al.
Published: (2006-12-01) -
The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatins⃞
by: Dawn E. Telford, et al.
Published: (2007-03-01) -
Ezetimibe potential in cardiology practice
by: A. A. Lyakishev, et al.
Published: (1970-01-01)